AI assistant
PFIZER INC — Director's Dealing 2015
Jan 5, 2015
29831_dirs_2015-01-05_d2ca9ccb-0062-4383-a21a-d1b5aa4e8c79.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2014-12-31
Reporting Person: LANKLER DOUGLAS M (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-31 | Common Stock | M | 21413.0000 | $18.1900 | Acquired | 127673.0000 | Direct |
| 2014-12-31 | Common Stock | F | 6215.0000 | $31.1500 | Disposed | 121458.0000 | Direct |
| 2014-12-31 | Common Stock | F | 9362.0000 | $31.5400 | Disposed | 112096.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | Stock Appreciation Rights | $18.1900 | M | 21413.0000 | Disposed | 2014-12-31 | Common Stock (21413.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1295.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.